Article ; Online: Antioxidant therapy as a potential approach to severe influenza-associated complications.
Molecules (Basel, Switzerland)
2011 Volume 16, Issue 3, Page(s) 2032–2052
Abstract: ... of antioxidant therapy as a potential approach to severe influenza-associated complications. ... influenza pandemic and many patients have died from severe complications associated with this pandemic ... for the treatment of patients with severe influenza-associated complications. This review article updates knowledge ...
| Abstract | With the appearance of the novel influenza A (H1N1) virus 2009 strain we have experienced a new influenza pandemic and many patients have died from severe complications associated with this pandemic despite receiving intensive care. This suggests that a definitive medical treatment for severe influenza-associated complications has not yet been established. Many studies have shown that superoxide anion produced by macrophages infiltrated into the virus-infected organs is implicated in the development of severe influenza-associated complications. Selected antioxidants, such as pyrrolidine dithiocabamate, N-acetyl-L-cysteine, glutathione, nordihydroguaiaretic acid, thujaplicin, resveratrol, (+)-vitisin A, ambroxol, ascorbic acid, 5,7,4-trihydroxy-8-methoxyflavone, catechins, quercetin 3-rhamnoside, iso- quercetin and oligonol, inhibit the proliferation of influenza virus and scavenge superoxide anion. The combination of antioxidants with antiviral drugs synergistically reduces the lethal effects of influenza virus infections. These results suggest that an agent with antiviral and antioxidant activities could be a drug of choice for the treatment of patients with severe influenza-associated complications. This review article updates knowledge of antioxidant therapy as a potential approach to severe influenza-associated complications. |
|---|---|
| MeSH term(s) | Antioxidants/therapeutic use ; Antiviral Agents/therapeutic use ; Humans ; Influenza A virus/isolation & purification ; Influenza, Human/complications ; Influenza, Human/drug therapy ; Influenza, Human/virology |
| Chemical Substances | Antioxidants ; Antiviral Agents |
| Language | English |
| Publishing date | 2011-02-28 |
| Publishing country | Switzerland |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
| ZDB-ID | 1413402-0 |
| ISSN | 1420-3049 ; 1431-5165 ; 1420-3049 |
| ISSN (online) | 1420-3049 |
| ISSN | 1431-5165 ; 1420-3049 |
| DOI | 10.3390/molecules16032032 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.MO 81: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.